The Tuberculosis Positive Conversion Rate Among Psoriasis Patients Treated with Adalimumab and Secukinumab: A Single-Center Retrospective Study in China

INTRODUCTION: The tuberculosis (TB) positive conversion rate among psoriasis patients who received biologics has been reported worldwide, particularly in regions with low TB risk. Nonetheless, the TB-related safety of biologics such as adalimumab and secukinumab remains elusive in areas with high TB...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Yue, Chen, Hui, Zou, Qin, Wang, Yiyi, Gu, Yuanxia, Wang, Jinqiu, Yan, Wei, Li, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133823/
https://www.ncbi.nlm.nih.gov/pubmed/35616884
http://dx.doi.org/10.1007/s13555-022-00745-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9133823/
https://www.ncbi.nlm.nih.gov/pubmed/35616884
http://dx.doi.org/10.1007/s13555-022-00745-7

Ejemplares similares